299 related items for PubMed ID: 34019881
1. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
Tanaka A, Inoue M, Hoshina T, Koga H.
J Pediatr; 2021 Sep; 236():95-100. PubMed ID: 34019881
[Abstract] [Full Text] [Related]
2. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, Sugitani Y, Kuraoka A, Mizuno Y, Sagawa K, Honjo S, Hara T, Ohga S.
J Pediatr; 2020 Dec; 227():224-230.e3. PubMed ID: 32810506
[Abstract] [Full Text] [Related]
3. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
4. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
[Abstract] [Full Text] [Related]
5. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
6. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H.
JAMA Netw Open; 2022 Jun 01; 5(6):e2216642. PubMed ID: 35696166
[Abstract] [Full Text] [Related]
7. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
J Pediatr; 2022 Jan 01; 240():158-163.e4. PubMed ID: 34461064
[Abstract] [Full Text] [Related]
8. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Jan 01; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
9. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Jan 01; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
10. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
[Abstract] [Full Text] [Related]
11. Patterns of Fever in Children After Primary Treatment for Kawasaki Disease.
Jaggi P, Wang W, Dvorchik I, Printz B, Berry E, Kovalchin JP, Texter K, Ramilo O, Burns JC, Tremoulet AH.
Pediatr Infect Dis J; 2015 Dec 15; 34(12):1315-8. PubMed ID: 26353031
[Abstract] [Full Text] [Related]
12. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Dec 15; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
13. Variability in Response to Intravenous Immunoglobulin in the Treatment of Kawasaki Disease.
Downie ML, Manlhiot C, Latino GA, Collins TH, Chahal N, Yeung RS, McCrindle BW.
J Pediatr; 2016 Dec 15; 179():124-130.e1. PubMed ID: 27659027
[Abstract] [Full Text] [Related]
14. Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms.
Selamet Tierney ES, Runeckles K, Tremoulet AH, Dahdah N, Portman MA, Mackie AS, Harahsheh AS, Lang SM, Choueiter NF, Li JS, Manlhiot C, Low T, Mathew M, Friedman KG, Raghuveer G, Norozi K, Szmuszkovicz JR, McCrindle BW, International Kawasaki Disease Registry.
J Pediatr; 2022 Jan 15; 240():164-170.e1. PubMed ID: 34474088
[Abstract] [Full Text] [Related]
15. Platelet Count Variation and Risk for Coronary Artery Abnormalities in Kawasaki Disease.
Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Shindo A, Kuwabara M, Makino N, Matsubara Y, Kosami K, Sasahara T, Belay ED.
Pediatr Infect Dis J; 2020 Mar 15; 39(3):197-203. PubMed ID: 31851145
[Abstract] [Full Text] [Related]
16. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
Yanagimoto K, Nomura Y, Masuda K, Hirabayashi M, Morita Y, Yoshishige M, Ueno K, Eguchi T, Kawano Y.
Int Arch Allergy Immunol; 2014 Mar 15; 164(2):83-8. PubMed ID: 24903098
[Abstract] [Full Text] [Related]
17. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
Liu J, Su D, Yuan P, Ye B, Qin S, Pang Y.
Cardiology; 2023 Mar 15; 148(5):457-468. PubMed ID: 37231847
[Abstract] [Full Text] [Related]
18. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
Am J Ther; 2016 Mar 15; 23(6):e1293-e1299. PubMed ID: 25611359
[Abstract] [Full Text] [Related]
19. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S, KIDCARE Multicenter Study Group.
Lancet Child Adolesc Health; 2021 Dec 15; 5(12):852-861. PubMed ID: 34715057
[Abstract] [Full Text] [Related]
20. Low risk of treatment resistance in Down syndrome with Kawasaki disease.
Takatsuki S, Ogata S, Ishii M, Yokozawa M, Ono M, Fujiwara M, Ida H, Motomura H, Moriuchi H, Taketazu M, Kawamura Y, Kawano T, Izumi T, Shiono J, Tsuchiya S, Tsuchiya K, Goushi T, Ichida F, Saji T.
Pediatr Int; 2017 Dec 15; 59(12):1236-1239. PubMed ID: 28960680
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
